EE355 Pre-Progression Health State Utility Values From the TALAPRO-2 Clinical Trial in Patients With Metastatic Castration-Resistant Prostate Cancer With HRR Mutations

Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.621
https://www.valueinhealthjournal.com/article/S1098-3015(23)03751-8/fulltext
Section Title :
Section Order : 10106
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03751-8&doi=10.1016/j.jval.2023.09.621
HEOR Topics :
Tags :
Regions :